Hospital
University Community Hospital, INC
University Community Hospital, INC was paid $10.25M by Medicaid between Jan 2018 and Dec 2024, across 158 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.
33Billing provider infoUNIVERSITY COMMUNITY HOSPITAL, INC
TAMPA, FL 33614
TAMPA, FL 33614
33aNPI1427068345assigned 08/09/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.25M
24GClaims418,553
24DCodes billed158
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#51 of 163
Median peer was paid$4.77M
This provider vs. median2.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,673 | $374K | |
| 2019 | 85,384 | $1.41M | |
| 2020 | 68,647 | $1.47M | |
| 2021 | 85,140 | $2.17M | |
| 2022 | 71,702 | $1.85M | |
| 2023 | 48,522 | $1.80M | |
| 2024incomplete | 26,485 | $1.18M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 30,768 | 27,526 | $2.21M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 24,838 | 21,138 | $1.81M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.7% | 10,111 | 8,430 | $686K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.1% | 14,604 | 11,966 | $620K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.0% | 3,122 | 2,583 | $406K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3.7% | 4,528 | 3,724 | $375K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3.1% | 2,079 | 1,737 | $316K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.0% | 8,304 | 6,624 | $312K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.0% | 3,538 | 2,844 | $306K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.8% | 3,997 | 3,646 | $288K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.7% | 6,572 | 6,069 | $275K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.9% | 9,752 | 7,438 | $198K |
146 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.7% | 4,024 | $169K |
| 80053 | Comprehensive metabolic panel | 1.6% | 25,207 | $166K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.5% | 2,415 | $156K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.5% | 1,596 | $155K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.4% | 2,213 | $143K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 3,707 | $131K |
| 81025 | 1.1% | 5,424 | $108K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,789 | $98K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,389 | $86K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 6,449 | $80K |
| 82947 | <1% | 8,253 | $72K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,238 | $69K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,859 | $65K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 619 | $57K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 765 | $50K |
| 01999 | <1% | 1,898 | $46K | |
| 76830 | Ultrasound, transvaginal | <1% | 726 | $46K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,744 | $46K |
| 71045 | Radiologic examination, chest; single view | <1% | 10,915 | $44K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,822 | $44K |
| G0378 | Hospital observation service, per hour | <1% | 5,019 | $43K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,636 | $36K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,252 | $34K |
| 81001 | <1% | 12,298 | $27K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 730 | $23K |
| 73610 | <1% | 604 | $23K | |
| 81003 | <1% | 5,190 | $22K | |
| 87070 | <1% | 1,085 | $19K | |
| 73130 | <1% | 652 | $19K | |
| 73630 | <1% | 656 | $18K | |
| 11043 | <1% | 150 | $18K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 29,883 | $17K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12,768 | $17K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 199 | $17K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,189 | $14K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 12,592 | $13K |
| 87186 | <1% | 2,141 | $13K | |
| 87210 | <1% | 1,761 | $12K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,420 | $12K |
| 96376 | <1% | 3,027 | $11K | |
| 73564 | <1% | 446 | $11K | |
| 73030 | <1% | 357 | $11K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 467 | $11K |
| 84484 | <1% | 12,212 | $11K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 29 | $10K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 683 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,656 | $8K |
| 87807 | <1% | 611 | $8K | |
| 84703 | <1% | 9,631 | $7K | |
| 73110 | <1% | 182 | $6K | |
| 83690 | <1% | 9,029 | $6K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 8,791 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,997 | $5K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 259 | $5K |
| 93971 | <1% | 341 | $5K | |
| 80050 | General health panel | <1% | 162 | $5K |
| 74019 | <1% | 223 | $4K | |
| 86901 | <1% | 467 | $4K | |
| 85610 | <1% | 2,377 | $4K | |
| 12001 | <1% | 43 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,980 | $3K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 31 | $3K |
| 84702 | <1% | 1,933 | $3K | |
| 83735 | <1% | 3,351 | $3K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 13 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 557 | $3K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,142 | $3K |
| 85730 | <1% | 1,489 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,385 | $3K |
| 87040 | <1% | 4,370 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,921 | $3K |
| 83880 | <1% | 2,144 | $3K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 817 | $2K |
| 74018 | <1% | 75 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,164 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,952 | $2K |
| 82077 | <1% | 190 | $2K | |
| 74022 | <1% | 103 | $2K | |
| 87077 | <1% | 1,642 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,146 | $2K |
| 80061 | Lipid panel | <1% | 573 | $1K |
| 76801 | <1% | 845 | $1K | |
| 10060 | <1% | 28 | $1K | |
| 83605 | <1% | 2,923 | $1K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,587 | $1K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 511 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 340 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 565 | $786.54 |
| 82550 | <1% | 508 | $758.95 | |
| 97162 | <1% | 16 | $749.59 | |
| 72110 | <1% | 45 | $630.37 | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 38 | $615.96 |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 18 | $540.07 |
| 73502 | <1% | 31 | $491.58 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,111 | $426.37 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,214 | $389.44 |
| 73090 | <1% | 15 | $360.58 | |
| 87430 | <1% | 204 | $310.63 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,128 | $281.16 |
| 85027 | <1% | 790 | $259.09 | |
| 90715 | <1% | 316 | $244.45 | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 15 | $242.12 |
| 85379 | <1% | 1,076 | $213.85 | |
| 84132 | <1% | 83 | $195.75 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,012 | $179.79 |
| 87641 | <1% | 106 | $162.96 | |
| 0001A | <1% | 29 | $156.80 | |
| G1010 | Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program | <1% | 55 | $133.29 |
| 93017 | <1% | 19 | $115.57 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 14 | $85.70 |
| 86140 | <1% | 187 | $75.39 | |
| 93970 | <1% | 32 | $69.35 | |
| 86850 | <1% | 103 | $67.42 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 605 | $58.86 |
| 82565 | <1% | 62 | $43.07 | |
| 97116 | <1% | 155 | $41.76 | |
| 88342 | <1% | 745 | $32.46 | |
| 86900 | <1% | 394 | $18.29 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 266 | $6.80 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 192 | $6.72 |
| 73562 | 0% | 14 | $0.00 | |
| 84145 | 0% | 121 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 196 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 77 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 123 | $0.00 |
| 29125 | 0% | 14 | $0.00 | |
| J2800 | Injection, methocarbamol, up to 10 ml | 0% | 13 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 34 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 25 | $0.00 |
| 85007 | 0% | 13 | $0.00 | |
| 85014 | 0% | 32 | $0.00 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 18 | $0.00 |
| 0002A | 0% | 14 | $0.00 | |
| 84295 | 0% | 15 | $0.00 | |
| 85652 | 0% | 74 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 977 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 14 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 152 | $0.00 |
| 94760 | 0% | 388 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 231 | $0.00 |
| 94762 | 0% | 20 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 61 | $0.00 |
| C1769 | Guide wire | 0% | 17 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 14 | $0.00 |
| 82330 | 0% | 17 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 38 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSAUDER, CHRISTOPHER (CFO)